Skip to main content
TipRanks
Go Ultimate75% OFF

Kristine Ball Insider Profile

4 Followers

Kristine Ball, Director at Oruka Therapeutics, holds 0.00 shares in Oruka Therapeutics (Ticker: ORKA), holds 52.53K shares in Yarrow Bioscience (Ticker: YARW), holds 21.29K shares in Relypsa Inc (Ticker: RLYP).

Kristine Ball's Trading History

ORKA
Oruka Therapeutics
Nov 13, 2026DirectorUninformative Buy123.12K$0.00
YARW
Yarrow Bioscience
Dec 13, 2019SVP, Corporate Strategy and CFOUninformative Buy237.45K$746.51K
RLYP
Relypsa Inc
Aug 17, 2016―Uninformative Sell47.20K$681.07K
EXEL
Exelixis
―Controller & Interim CFO―$1.13M
BCEL
Atreca
――――
FTSV
Forty Seven
――――

You May Also Like

Kristine Ball insider profile FAQ

What stocks does Kristine Ball hold?
Kristine Ball holds: ORKA, RLYP, YARW, FTSV, BCEL, EXEL stocks.
What was Kristine Ball’s latest transaction?
Kristine Ball’s latest transaction was an Uninformative Buy of $123.12K.
What was Kristine Ball's most profitable transaction?
Kristine Ball’s most profitable transaction was an Informative Sell of RLYP stock on August 19, 2015. The return on the trade was 50.80%.
What is Kristine Ball's role in Oruka Therapeutics?
Kristine Ball's role in Oruka Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.